Healthy postmenopausal women receiving hrt are not at risk for early coronary events: Results from 2 large clinical trials

被引：0
|
作者：
Constantine, GD [1 ]
Pickar, JH [1 ]
Trott, EA [1 ]
机构：
[1] Wyeth Ayerst Res, St Petersburg 191011, Russia
来源：
WOMEN'S HEALTH AND MENOPAUSE: NEW STRATEGIES - IMPROVED QUALITY OF LIFE | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：231 / 238
页数：8
相关论文
共 50 条
  • [31] Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women
    F Clavel-Chapelon
    British Journal of Cancer, 2002, 86 : 723 - 727
  • [32] Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women
    Clavel-Chapelon, F
    BRITISH JOURNAL OF CANCER, 2002, 86 (05) : 723 - 727
  • [33] Effects of hormone replacement therapy on cognitive aging and dementia risk in postmenopausal women: a review of ongoing large-scale, long-term clinical trials
    Zec, RF
    Trivedi, MA
    CLIMACTERIC, 2002, 5 (02) : 122 - 134
  • [34] Pardoprunox in Early Parkinson's Disease: Results from 2 Large, Randomized Double-Blind Trials
    Sampaio, Cristina
    Bronzova, Juliana
    Hauser, Robert A.
    Lang, Anthony E.
    Rascol, Olivier
    van de Witte, Serge V.
    Theeuwes, Ad
    MOVEMENT DISORDERS, 2011, 26 (08) : 1464 - 1476
  • [35] Discordant Association of C-Reactive Protein With Clinical Events and Coronary Luminal Narrowing in Postmenopausal Women: Data From the Women's Angiographic Vitamin and Estrogen (WAVE) Study
    Patel, Dhavalkumar
    Jhamnani, Sunny
    Ahmad, Soha
    Silverman, Angela
    Lindsay, Joseph
    CLINICAL CARDIOLOGY, 2013, 36 (09) : 535 - 541
  • [36] Back pain risk is reduced in postmenopausal women with osteoporosis treated with teriparatide as compared with alendronate: Results from two double-blinded comparator trials
    Dore, RK
    Krege, JH
    Chen, P
    Glass, EV
    San Martin, J
    Miller, PD
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S98 - S99
  • [37] Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial
    Ettinger, B
    Black, DM
    Mitlak, BH
    Knickerbocker, RK
    Nickelsen, T
    Genant, HK
    Christiansen, C
    Delmas, PD
    Zanchetta, JR
    Stakkestad, J
    Glüer, CC
    Krueger, K
    Cohen, FJ
    Eckert, S
    Ensrud, KE
    Avioli, LV
    Lips, P
    Cummings, SR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07): : 637 - 645
  • [38] Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial
    Delmas, PD
    Ensrud, KE
    Adachi, JD
    Harper, KD
    Sarkar, S
    Gennari, C
    Reginster, JY
    Pols, HAP
    Recker, RR
    Harris, ST
    Wu, WT
    Genant, HK
    Black, DM
    Eastell, R
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08): : 3609 - 3617
  • [39] Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women. the EPIC-Norfolk study
    Simon, Tabassome
    Mallat, Ziad
    Benassiano, Joelle
    Edhery, Stephane
    Sebella-Arguelles, Carla
    Cohen, Ariel
    Huart, Virginie
    Wareham, Nicholas J.
    Luben, Robert
    Khaw, Kay-Tee
    Tedgui, Alain
    Boekholdt, Matthijs
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 14B - 14B
  • [40] Hostility scores are associated with increased risk of events in women undergoing coronary angiography: Results from the NHLBI-sponsored WISE study
    Olson, MB
    Merz, NB
    Kelsey, SF
    Pepine, CJ
    Sopko, G
    Rogers, WJ
    Mankad, S
    Phankao, C
    Krantz, D
    CIRCULATION, 2003, 108 (17) : 716 - 716
12345